Risk factors for thrombosis in nonembolic cerebrovascular disease

American Journal of Hematology

Volumn 60, Issue 3, 1999, Pages 239-241

  Mohanty, Sujata ^a   Saxena, Renu ^a,b   Behari, Madhuri ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Nonembolic cerebrovascular disease; Risk factors

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; PROTEIN S;

ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; HEMATOLOGICAL PARAMETERS; HUMAN; IDIOPATHIC DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; RISK FACTORS;

EID: 0033013696     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199903)60:3<239::AID-AJH14>3.0.CO;2-9     Document Type: Article

References (10)

1. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990;40: 1190.
2. Dhalback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C - prediction of a cofactor to activated protein C. Proc Natl Acad Sci 1993;90:1004.
3. Trossaent M, Conarel J, Horrelou MH, Samaina MM. Ireland H. Bayston TA, Lane DA. Modified APC resistance assay tor patients on oral anticoagulants. Lancet 1994;344:1709.
4. Dacie JV. Lewis SM. Practical haematology. Edinburgh: Churchill Livingstone, 8th ed. 1994.
5. Saxena R, Saraya AK, Kotte VK, Singh YN, Prasad L, Malviya AN. Inosithin neutralisation test for quantitation of LA. Am J Clin Pathol 1993;99:61.
6. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994;344:1163.
7. Garewal G, Das R, Trehan U. Factor V prevalence in the indigenous population and cases of thrombosis in North India. Br J Haematol 1997;97:940.
8. Saxena R, Mohanty S, Srivastava A, Choudhry VP, Kotwal J. Activated protein C (APC) resistance in Indian juvenile deep vein thrombosis. Thromb Res 1998 (in press).
9. Cushman M, Bhushan F, Bovil E, Tracy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994;72:643.
10. Halbmayer WN, Haushofer A, Schon R, Fisher M. Prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from non-embolic cerebral arterial infarction or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis 5:51, 1994.